Activity of an antimicrobial hydrocephalus shunt catheter against Propionibacterium acnes

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 12, 2010, Pages 5082-5085

  Bayston, Roger ^a   Vera, Litza ^a   Ashraf, Waheed ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; RIFAMPICIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL CATHETER; ARTICLE; BACTERIAL COLONIZATION; CATHETER; CONTROLLED STUDY; HYDROCEPHALUS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SHUNT INFECTION; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; CATHETERS; CEREBROSPINAL FLUID SHUNTS; HYDROCEPHALUS; PROPIONIBACTERIUM ACNES;

EID: 78649669810     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00540-10     Document Type: Article

References (33)

1. Arnell, K., K. Cesarini, A. Lagerqvist-Widh, T. Wester, and J. Sjölin. 2008. Cerebrospinal fluid shunt infections in children over a 13-year period: anaerobic cultures and comparison of clinical signs of infection with Propionibacterium acnes and with other bacteria. J. Neurosurg. Pediatr. 1:366-372.
2. Bafeltowska, J. J., E. Buszman, K. M. Mandat, and J. K. Hawranek. 2004. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections. Surg. Neurol. 62:142-150.
3. Barazi, S., K. K. Gnanalingham, I. Chopra, and J. R. van Dellen. 2003. Delayed postoperative intracerebral abscess caused by Propionibacterium acnes: case report and review of the literature. Br. J. Neurosurg. 17:336-339.
4. Bayston, R., W. Ashraf, R. Barker-Davies, E. Tucker, R. Clement, J. Clayton, B. J. C. Freeman, and B. Nuradeen. 2007. Biofilm formation by Propionibacterium acnes on biomaterials in vitro and in vivo: impact on diagnosis and treatment. J. Biomed. Mater. Res. 81A:705-709.
5. Bayston, R., W. Ashraf, and C. Bhundia. 2004. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J. Antimicrob. Chemother. 53:778-782.
6. Bayston, R., C. Bannister, V. Boston, R. Burman, B. Burns, F. Cooke, R. Cooke, R. Cudmore, R. Fitzgerald, C. Goldberg, H. T. Green, E. Guiney, C. Hardwidge, C. A. Hart, A. E. Holmes, J. Meigh, J. Miles, A. Rampling, J. Walker, H. Webb, and K. Whale. 1990. A prospective randomised controlled trial of antimicrobial prophylaxis in hydrocephalus shunt surgery. Z. Kinderchirurg. 45:5-7.
7. Bayston, R., L. Fisher, and K. Weber. 2009. An antimicrobial modified silicone peritoneal catheter with activity against both Gram positive and Gram negative bacteria. Biomaterials 30:3167-3173.
8. Bayston, R., N. Grove, J. Siegel, D. Lawellin, and S. Barsham. 1989. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J. Neurol. Neurosurg. Psychiatr. 52:605-609.
9. Bayston, R., and E. Lambert. 1997. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J. Neurosurg. 87:247-251.
10. Bayston, R., L. Vera, A. Mills, W. Ashraf, O. Stevenson, and S. M. Howdle. 2010. In vitro antimicrobial activity of silver-processed catheters for neurosurgery. J. Antimicrob. Chemother. 65:258-265.
11. Coenye, T., E. Peeters, and H. J. Nelis. 2007. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res. Microbiol. 158:386-392.
12. Critchley, G., and R. Strachan. 1996. Postoperative subdural empyema caused by Propionibacterium acnes - a report of two cases. Br. J. Neurosurg. 10:321-323.
13. Duhaime, A. C. 2006. Evaluation and management of shunt infections in children with hydrocephalus. Clin. Pediatr. 45:705-713.
14. Eymann, R., S. Chehab, M. Strowitzki, W.-I. Steudel, and M. Kiefer. 2008. Clinical and economic consequences of antibiotic impregnated cerebrospinal fluid shunt catheters. J. Neurosurg. Pediatr. 1:444-450.
15. Frenz, G., P. B. Nielsen, F. Espersen, A. Czartoryski, and H. Aastrup. 1984. Penicillin concentrations in blood and spinal fluid after a single intramuscular injection of penicillin G benzathine. Eur. J. Clin. Microbiol. 3:147-149.
16. Govender, S. T., N. Nathoo, and J. R. van Dellen. 2003. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J. Neurosurg. 99:831-839. (Pubitemid 37314917)
17. Jorgensen, L., P. D. Reiter, J. E. Freeman, K. R. Winston, D. Fish, L. A. McBride, and M. H. Handler. 2007. Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices. Pediatr. Neurosurg. 43:449-455.
18. Kulkarni, A. V., J. M. Drake, and M. Lamberti-Pasculli. 2001. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J. Neurosurg. 94:195-201.
19. Lackner, P., R. Beer, G. Broessner, R. Helbok, K. Galiano, C. Pleifer, B. Pfausler, C. Brennais, C. Huck, K. Engelhardt, A. A. Obwegeser, and E. Schmutzhard. 2008. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit. Care. 8:360-365.
20. LeRoux, P., M. A. Howard, and H. R. Winn. 1990. Vancomycin pharmacokinetics in hydrocephalus shunt prophylaxis and relationship to ventricular volume. Surg. Neurol. 34:366-372.
21. Müller, C., A. Netland, A. F. Dawson, and E. Andrew. 1980. The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges. J. Antimicrob. Chemother. 6:279-283.
22. Nau, R., H. W. Prange, P. Muth, G. Mahr, S. Menck, H. Kolenda, and F. Sörgel. 1993. Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob. Agents Chemother. 37:1518-1524.
23. Nisbet, M., S. Briggs, R. Ellis-Pegler, M. Thomas, and D. Holland. 2007. Propionibacterium acnes: an under-appreciated cause of post-neurosurgical infection. J. Antimicrob. Chemother. 60:1097-1103.
24. Parker, S. L., F. J. Attenello, D. M. Sciubba, G. L. Garces-Ambrossi, E. Ahn, J. Weingart, B. Carson, and G. Jallo. 2009. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv. Syst. 25:77-83.
25. Patel, R. 2005. Biofilms and antimicrobial resistance. Clin. Orthop. Relat. Res. 437:41-47.
26. Pattavilakom, A., C. Xenos, O. Bradfield, and R. A. Danks. 2007. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J. Clin. Neurosci. 14:526-531.
27. Ragel, B. T., S. R. Brown, and R. H. Schmidt. 2006. Surgical shunt infection: significant reduction when using intraventricular and systemic agents. J. Neurosurg. 105:242-247.
28. Richards, S. R., and K. M. Emara. 2001. Delayed infections after posterior TSRH spinal instrumentation for idiopathic scoliosis. Spine 26:1990-1996.
29. Sciubba, D. M., L.-M. Lin, G. F. Woodworth, M. J. McGirt, B. Carson, and G. I. Jallo. 2007. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic-impregnated components. Neurosurg. Focus. 22:1-4.
30. Thompson, T. P., and A. L. Albright. 1998. Propionibacterium acnes infections of cerebrospinal fluid shunts. Childs Nerv. Syst. 14:378-380.
31. Viraraghavan, R., B. Jantausch, and J. Campos. 2004. Late-onset central nervous system shunt infections with Propionibacterium acnes: diagnosis and management. Clin. Pediatr. 43:393-397.
32. Younger, J. J., J. C. H. Simmons, and F. F. Barrett. 1987. Failure of single dose intraventricular vancomycin for cerebrospinal fluid shunt surgery prophylaxis. Pediatr. Infect. Dis. J. 6:212-213.
33. Zabramski, J. M., D. Whiting, R. O. Darouiche, T. G. Horner, J. Olson, C. Robertson, and A. J. Hamilton. 2003. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J. Neurosurg. 98:725-730.